Conversely, while in the pivotal cohort IL-6 emerged as a differentially expressed antigen (PCa versus HD), in the training cohort the levels of IL-6 showed a modest, not significant trend of correlation with increasing pathological Tumor-Node-Metastasis (pTNM) staging (Fig. S8B). The gene discussed is IL6; the disease is posterior cortical atrophy.